81 related articles for article (PubMed ID: 2183339)
1. [Adjuvant medical treatment].
Plagne R; Chollet P; Legros M; Cure H; Ferrière JP; Bignon YJ
Rev Prat; 1990 Apr; 40(10):905-8. PubMed ID: 2183339
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy in early breast cancer.
Chittoor SR; Swain SM
Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy in breast cancer.
Robert NJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
6. [Breast carcinoma--adjuvant chemo- and hormone therapy].
Fey MF
Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions].
Goldhirsch A; Neuenschwander H; Castiglione M; Senn HJ; Cavalli F
Schweiz Med Wochenschr; 1990 Nov; 120(47):1771-83. PubMed ID: 2255883
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant hormonal therapy for premenopausal women with breast cancer.
Brown RJ; Davidson NE
Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
[TBL] [Abstract][Full Text] [Related]
10. [Questions and answers on adjuvant systemic therapy in breast carcinoma].
Fey MF; Castiglione-Gertsch M
Ther Umsch; 1996 Nov; 53(11):839-46. PubMed ID: 8984689
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
12. [Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases].
Roy JA; Piccart MJ
Rev Med Brux; 1995; 16(4):242-4. PubMed ID: 7481234
[TBL] [Abstract][Full Text] [Related]
13. Hormonal manipulation in the adjuvant treatment of breast cancer.
Honig SF; Swain SM
Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
[No Abstract] [Full Text] [Related]
14. [Chemo-endocrine therapy of advanced breast cancer].
Nomura Y
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3214-20. PubMed ID: 2973769
[TBL] [Abstract][Full Text] [Related]
15. Systemic adjuvant therapy of breast cancer.
O'Connell J
Conn Med; 1999 Jan; 63(1):29-33. PubMed ID: 10071436
[TBL] [Abstract][Full Text] [Related]
16. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
18. [Progress in breast cancer chemo-endocrine therapy from the survival standpoint].
Nomura Y
Gan To Kagaku Ryoho; 1995 May; 22(6):726-31. PubMed ID: 7755380
[TBL] [Abstract][Full Text] [Related]
19. Testing "the soft option": trials of adjuvant endocrine therapy for the primary treatment of breast cancer.
Ebbs SR; Baum M
Isr J Med Sci; 1988; 24(9-10):552-6. PubMed ID: 3060445
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
